Featured Articles

Rare Disease Patient Voice

Rare Disease Patient Voice Kendall Davis Manager, Patient Advocacy & Engagement PRA will be at the 2018 RARE Patient Advocacy Summit in Irvine, California, the largest gathering of rare disease patients, advocates, and thought leaders worldwide. OCTOBER 3, 2018 The...

Is Marijuana a Replacement for Opioids?

Is Marijuana a Replacement for Opioids? Lynn R. Webster, M.D. Vice President, Scientific Affairs Dr. Webster will be presenting a poster at DIA 2018 in Boston on Tuesday, June 26 on A Phase 1 Pilot Trial to Explore Safety, Pharmacokinetics, and Bioavailability of...

Winning Team: Working With a Service Dog

  Winning Team: Working With a Service Dog   Billy DeWalt and his wife, Jen Note from Billy: If anyone reading this wants to jump in on the Tobacco Road Marathon, feel free! The course is great for beginners to seasoned runners and is also walker and ruck friendly. If...

More Posts

Bridging Recruitment Gaps with Academic Collaboration

  Bridging Recruitment Gaps with Academic Collaboration   Dr. Alexandre Malouvier, Scientific Affairs Director, Real World Solutions DECEMBER 5, 2018 As the pharmaceutical industry is rapidly changing, many roles and relationships within it are going through a major...

read more

Winning Team: Working With a Service Dog

  Winning Team: Working With a Service Dog   Billy DeWalt and his wife, Jen Note from Billy: If anyone reading this wants to jump in on the Tobacco Road Marathon, feel free! The course is great for beginners to seasoned runners and is also walker and ruck friendly. If...

read more

Making Clinical Trial Recruitment More Efficient

  Making Clinical Trial Recruitment More Efficient   Larissa Silva, MD Buenos Aires, Argentina   Rebecca Sayers, PhD Raleigh, North Carolina, United States   Jens Dietrich, PhD Berlin, Germany   Russell Brown, PharmD, PhD South Yarra, Victoria, Australia NOVEMBER 26,...

read more

Lung Cancer Awareness Month

  Lung Cancer Awareness Month Stephen Huff Founder of The Huff Project NOVEMBER 6, 2018 Stephen Huff was diagnosed with stage IV inoperable lung cancer at the age of 29. Prior to his diagnosis, Stephen lived an incredibly healthy and clean lifestyle. As a former...

read more

Literature Surveillance: From Abundance to Relevance

  Literature Surveillance: From Abundance to Relevance Andrew Purchase Associate Director of Patient Safety Operations, PV and Patient Safety NOVEMBER 1, 2018 Literature is regarded as a significant source of information in the monitoring of a medicinal product, and...

read more

Advocacy Groups in Patient-Focused Drug Development

  Advocacy Groups in Patient-Focused Drug Development Juliane K. Mills Director, Real World Solutions -  Scientific Affairs Kendall Davis Manager, Patient Advocacy & Engagement Juliane Mills hosted an Xtalks webinar on Thursday, November 8, 2018 to discuss how the...

read more

When Volunteering is Part of Who You Are

  When Volunteering is Part of Who You Are Mark Sorrentino VP, The Center for Pediatric Clinical Development OCTOBER 24, 2018 At PRA, a tremendous number of our colleagues volunteer their time, as well as donate supplies and funds, to help support scientific research...

read more

Children in Clinical Research

  Children in Clinical Research Harris Dalrymple Director of Scientific Affairs PRA is a proud presenting sponsor of ACS CAN's ninth annual Research Breakfast, which focuses on the barriers to cancer clinical trial enrollments and efforts to overcome them. OCTOBER 10,...

read more

Biologic Agents for the Treatment of Rheumatoid Arthritis

  Biologic Agents for the Treatment of Rheumatoid Arthritis Maria Victoria Hernandez MD, PhD Medical Director, Rheumatology - Medical Affairs OCTOBER 9, 2018 Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease affecting around 1.5 million people...

read more

Updates

Neurodegenerative Research: A Future Mindset

PRA’s William Holt, DO, discusses the critical need for research into Neurodegenerative disorders, with particular emphasis on the future of clinical development and Alzheimer’s Disease research.